Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
16 mai 2023 08h05 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Reports First Quarter 2023 Results
10 mai 2023 07h07 HE
|
Syneos Health, Inc.
Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Appoints Michael Bonello as Chief Financial Officer
02 mai 2023 06h19 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
13 avr. 2023 16h31 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...
Syneos Health Names Jeanine O’Kane as Communications President
04 avr. 2023 14h05 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine O’Kane as President...
Syneos Health Launches Medical Affairs Digital Amplifier
27 mars 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical...
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
22 mars 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
20 mars 2023 06h45 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year...
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
08 févr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
07 févr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...